MRKRHealthcareNano-Cap
Marker Therapeutics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Marker Therapeutics, Inc. (MRKR), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are MRKR insiders buying or selling?
Marker Therapeutics, Inc. insiders reported 20 open-market buys ($111.5M) and 0 sells ($0) across 20 Form 4 filings — a net buying position of $111.5M.
Source: SEC EDGAR Form 4
Key Statistics (as of Dec 26, 2024)
Total Form 4 filings
20
SEC EDGAR
Insider filers
17
Insider buys (20)
$111.5M
Insider sells (0)
$0
Insider sentiment
Net buyingNet insider flow of $111.5M in net buying.
Recent MRKR insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 26, 2024 | ELMS STEVE | Director | Purchase | 11.1K | $3.20 | $35.5K |
| Dec 23, 2024 | Forest Baskett | 10% Owner | Purchase | 554.3K | $3.20 | $1.8M |
| Jun 9, 2023 | Norman David Eansor | Director | Purchase | 14.3K | $17.50 | $250.0K |
| May 20, 2021 | Frederick Gerald Wasserman | Director | Purchase | 10.0K | $2.41 | $24.1K |
| Mar 18, 2021 | Paul Edward Walker | 10% Owner | Purchase | 5.7M | $1.75 | $10.0M |
| Mar 18, 2021 | Peter W. Sonsini | 10% Owner | Purchase | 5.7M | $1.75 | $10.0M |
| Mar 18, 2021 | Scott D Sandell | 10% Owner | Purchase | 5.7M | $1.75 | $10.0M |
| Mar 18, 2021 | Joshua Makower | 10% Owner | Purchase | 5.7M | $1.75 | $10.0M |
| Mar 18, 2021 | Mohamad Makhzoumi | 10% Owner | Purchase | 5.7M | $1.75 | $10.0M |
| Mar 18, 2021 | Anthony A. Florence Jr. | 10% Owner | Purchase | 5.7M | $1.75 | $10.0M |
| Mar 18, 2021 | Carmen Chang | 10% Owner | Purchase | 5.7M | $1.75 | $10.0M |
| Mar 18, 2021 | Ali Behbahani | 10% Owner | Purchase | 5.7M | $1.75 | $10.0M |
| Mar 18, 2021 | Forest Baskett | 10% Owner | Purchase | 5.7M | $1.75 | $10.0M |
| Mar 18, 2021 | New Enterprise Associates 16, L.P. | 10% Owner | Purchase | 5.7M | $1.75 | $10.0M |
| Mar 18, 2021 | Wilson John Robert | Director | Purchase | 1.7M | $1.75 | $3.0M |
| Mar 18, 2021 | Vera Juan | Chief Development Officer | Purchase | 571.4K | $1.75 | $1000.0K |
| Mar 18, 2021 | Peter L. Hoang | President and CEO | Purchase | 142.9K | $1.75 | $250.0K |
| Mar 18, 2021 | ELMS STEVE | Director | Purchase | 1.1M | $1.75 | $2.0M |
| Aug 15, 2019 | Peter L. Hoang | President and CEO | Purchase | 10.0K | $4.62 | $46.2K |
| May 16, 2018 | Eastern Capital LTD | 10% Owner | Purchase | 1.3M | $2.40 | $3.1M |
Showing the 20 most recent of 20 Form 4 filings for Marker Therapeutics, Inc..
Most active MRKR insiders
- ELMS STEVE2 filings
- New Enterprise Associates 16, L.P.2 filings
- Peter L. Hoang2 filings
- Ali Behbahani1 filing
- Anthony A. Florence Jr.1 filing
Ask anything about MRKR insider activity
Use Trabud's AI agent to query Marker Therapeutics, Inc.'s Form 4 history in plain English — "Show me MRKR CEO purchases this year" or compare it against any other ticker.
Open the AI agentMRKR insider trading FAQ
Are Marker Therapeutics, Inc. insiders buying or selling?
Across 20 SEC Form 4 filings, Marker Therapeutics, Inc. (MRKR) insiders reported 20 open-market purchases totaling $111.5M and 0 sales totaling $0. That is a net buying position of $111.5M.
How many insiders trade MRKR stock?
17 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Marker Therapeutics, Inc.. The most recent filing was accepted on Dec 26, 2024.
Where does Trabud get MRKR insider trading data?
All MRKR insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.